Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis

Abstract

SummaryBackgroundShigella infections are a leading cause of diarrhoeal death among children in low-income and middle-income countries. WHO guidelines reserve antibiotics for treating children with dysentery. Reliance on dysentery for identification and management of Shigella infection might miss an opportunity to reduce Shigella-associated morbidity and mortality. We aimed to systematically review and evaluate Shigella-associated and dysentery-associated mortality, the diagnostic value of dysentery for the identification of Shigella infection, and the efficacy of antibiotics for children with Shigella or dysentery, or both.MethodsWe did three systematic reviews (for mortality, diagnostic value, and antibiotic treatment of Shigella and dysentery), and meta-analyses where appropriate, of studies in resource-limited settings. We searched MEDLINE, Embase, and LILACS database for studies published before Jan 1, 2017, in English, French, and Spanish. We included studies of human beings with diarrhoea and accepted all study-specific definitions of dysentery. For the mortality and diagnostic value searches, we excluded studies that did not include an effect estimate or data necessary to calculate this estimate. The search for treatment included only randomised controlled trials that were done after Jan 1, 1980, and assessed antibiotics in children (aged <18 years) with dysentery or laboratory-confirmed Shigella. We extracted or calculated odds ratios (ORs) and 95% CIs for relative mortality and did random-effects meta-analysis to arrive at pooled ORs. We calculated 95% CIs assuming a binomial distribution and did random-effects meta-regression of log-transformed sensitivity and specificity estimates for diagnostic value. We assessed the heterogeneity of papers included in these meta-analyses using the I2 statistic and evaluated publication bias using funnel plots. This review is registered with PROSPERO (CRD42017063896).Findings3649 papers were identified and 60 studies were included for analyses: 13 for mortality, 27 for diagnostic value, and 20 for treatment. Shigella infection was associated with mortality (pooled OR 2·8, 95% CI 1·6–4·8; p=0·000) whereas dysentery was not associated with mortality (1·3, 0·7–2·3; p=0·37). Between 1977 and 2016, dysentery identified 1·9–85·9% of confirmed Shigella infections, with sensitivity decreasing over time (p=0·04). Ten (50%) of 20 included antibiotic trials were among children with dysentery, none were placebo-controlled, and two (10%) evaluated antibiotics no longer recommended for acute infectious diarrhoea. Ciprofloxacin showed superior microbiological, but not clinical, effectiveness compared with pivmecillinam, and no superior microbiological and clinical effectiveness compared with gatifloxacin. Substantial heterogeneity was reported for meta-analyses of the Shigella-associated mortality studies (I2=78·3%) and dysentery-associated mortality studies (I2=73·2%). Too few mortality studies were identified to meaningfully test for publication bias. No evidence of publication bi...

Epidemiological characteristics and transmissibility of shigellosis in Hubei Province, China, 2005 – 2017

“…Our findings of sex and age distribution showed that: 1) male individuals were more likely to be infected by Shigella spp than females; 2) individuals who were infants or old were more likely to be infected by the pathogen. These findings are similar to the epidemiological characteristics of shigellosis [24,32,33]. The intervention focusing on male, children, newborns and elders might be more effective to prevent and control the disease.…”

Global Emergency Medicine: A Review of the Literature From 2017

“…A systematic review on chikungunya virus infection-related rheumatic and musculoskeletal disorders identified chloroquine, hydroxychloroquine, disease-modifying antirheumatic drugs, corticosteroids, and nonsteroidal anti-inflammatory drugs as therapeutic options, but also highlights the lack of high-quality data to guide treatment decisions. 23 Tickell et al 28 performed a systematic review of Shigella infection in children. Dysenteric Shigella infections are often clinically obvious and are treated with antibiotics, but Shigella infections without symptoms of dysentery can be very difficult to detect.…”

Vying for the control of inflammasomes: The cytosolic frontier of enteric bacterial pathogen–host interactions

“…Infection by Shigella is a leading cause of diarrhoea in children in low‐ and middle‐income countries, where it is associated with high mortality rates (Tickell et al, ). There are four Shigella species, two of which ( S. flexneri and S. sonnei ) cause 90% of all infections.…”

“…Infection by Shigella is a leading cause of diarrhoea in children in lowand middle-income countries, where it is associated with high mortality rates (Tickell et al, 2017). Compared to studies with Salmonella, much less is currently known about the roles inflammasomes play during Shigella infection.…”